Back to
BlackRock Finance, Inc.
NRIX3 quarters
Position history for
BlackRock Finance, Inc.'s holdings in NURIX THERAPEUTICS INC
As of its last 13F, for Q2 2024, BlackRock Finance held 6,820,015 shares of NRIX (Nurix Therapeutics), worth $142.3M. It increased the position by 2,239,601 shares (+48.9%) from Q1 2024. BlackRock Finance held NRIX from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
$142.3M
Current Shares
6.8M
Total Value Change
+$94.4M
Total Shares Change
+2.2M
Quarter-by-Quarter History
Other major holders of NRIX: BlackRock, Inc., FMR LLC